CAR T-Cell, or chimeric antigen receptor immunotherapy was recently used in a study to see if it could help prevent the spread of metastatic cancer. In the study humanized CAR T-Cell was successful at killing tumor cells as well as preventing it from spreading. The treatment may be useful for treating other types of […]
Continue readingJohns Hopkins’ scientists have crafted a digital map, also called “ImmunoMap”, although still undergoing development, that can someday be used to identify which cancer patients will respond successfully to immunotherapies. This digital map addresses the variability of T-cell receptors which are chemical antennas that identify antigens and trigger an immune response. Through this digital map, […]
Continue reading